Search alternatives:
linear decrease » linear increase (Expand Search)
patent decrease » point decrease (Expand Search), content decreased (Expand Search), greatest decrease (Expand Search)
per decrease » teer decrease (Expand Search), we decrease (Expand Search), step decrease (Expand Search)
_ patent » _ patient (Expand Search), _ parent (Expand Search), _ patients (Expand Search)
linear decrease » linear increase (Expand Search)
patent decrease » point decrease (Expand Search), content decreased (Expand Search), greatest decrease (Expand Search)
per decrease » teer decrease (Expand Search), we decrease (Expand Search), step decrease (Expand Search)
_ patent » _ patient (Expand Search), _ parent (Expand Search), _ patients (Expand Search)
-
1
Overview of the six original ACTIV-3/TICO trials.
Published 2025“…However, there is concern that by neutralizing the SARS-CoV-2 virus, nMAbs may decrease the availability of antigens to the immune system, potentially impairing the endogenous polyclonal immune response and decreasing long-term immune protection.…”
-
2
-
3
-
4
-
5
-
6
Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025)
Published 2025Subjects: -
7
-
8
-
9
-
10
-
11
-
12
High-risk human papillomavirus prevalence stratified by age group and CD4 count category.
Published 2025Subjects: -
13
-
14
-
15
Baseline socio-demographic and clinical characteristics by multi-level hrHPV (N = 4,880).
Published 2025Subjects: -
16
Baseline socio-demographic and clinical characteristics by hrHPV positivity (N = 4,880).
Published 2025Subjects: -
17
Logistic regression model (N = 4,284) for variables associated with hrHPV positivity.
Published 2025Subjects: -
18
-
19
-
20